Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 1,951–1,978 of 1,978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00337532	A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer	completed	Phase 2 / Phase 3	50	Bristol-Myers SquibbINDUSTRY	1	Feb 4, 2010	clinicaltrials
NCT00855764	Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer	completed	Phase 2	36	Bristol-Myers SquibbINDUSTRY	0	Feb 4, 2010	clinicaltrials